Clinical Trial Update: Rituximab for Autoimmune Retinopathy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating rituximab for autoimmune retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Retinopathy

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Autoimmune Disease | Phase 1 | Status: COMPLETED